Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
Summary
GBI Research, the leading business intelligence provider, has released its latest report, Biomarkers in Cancer Research - High Unmet Need....
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
Summary
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars....
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
Summary
GBI Research, the leading business intelligence provider, has....
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth
Summary
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars i....
About Oncology Biosimilars
Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of th....
Facebook
Twitter
Google Plus
Linked In
RSS Feed
